The Origins of Curaderm
The developed product Curaderm is available to the public for the treatment of actinic keratoses and nonmelanoma skin cancers. The superiority of Curaderm over existing treatments for skin cancers has been amply described [1-6].
During the developmental stages of Curaderm, the mode of action of BEC as an anticancer agent was established. With this knowledge it was shown that BEC had other topical applications resulting in treatments for psoriasis, melanoma, and a sunscreen that is not only a preventative, but also a diagnostic that eliminates solar keratosis. These three latter products will be available to the public in 2024.
References
References
[1] Chase, T., Cham, K.E., Cham, B.E. (2020). Curaderm, the Long-Awaited Breakthrough for Basal Cell Carcinoma. International Journal Clinical
Medicine. 11(10). 579-604. Doi: 10.4236/ijcm.2020.1110050
[2] Chase, T.R., Cham, K.E., Cham, B.E. (2019). Solasodine Glycosides from the Eggplant in a Topical Cream PsorendBEC Are Effective against Psoriasis.
International Journal Clinical Medicine. 10(3), 174-182. Doi: 10.4236/ijcm.2019.103017
[3] Cham, B.E., (2020). First in Man Topical Treatment of Melanoma with Solasodine Glycosides in a Formulation Curaderm: A Case Report. Journal
Cancer Therapy. 11(10), 617-630. Doi: 10.4236/jct.2020.1110052
[4] Cham, B.E. (2013). Inspired by Nature, Proven by Science. The New Generation Cancer Treatment That Causes Cancer Cells to Commit Suicide.
Colorite Graphics, book. ISBN=978-1-62951-158-0.
[5] Cham, B.E. (2021). The Evolution of Curaderm which led to the Revolution of Skin Cancer treatment. ebook. Amazon US:
[6] Cham, B.E. (2022). The Pharmacology of Curaderm in the Treatment of Basal Cell Carcinoma. Clinical Medicine International Library.
Doi: 10.23937/2378-3656/1410399
